Primary carcinoma of the fallopian tube: Comparative genomic hybridization reveals high genetic instability and a specific, recurring pattern of chromosomal aberrations

International Journal of Gynecological Pathology

Volumn 17, Issue 3, 1998, Pages 245-254

  Heselmeyer, Kerstin ^a   Hellström, Ann Cathrin ^b   Blegen, Harald ^b   Schröck, Evelin ^a   Silfverswärd, Claes ^b   Shah, Keerti ^c   Auer, Gert ^b   Ried, Thomas ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cancer; Chromosome aberrations; Comparative genomic hybridization (CGH); DNA ploidy; Fallopian tube; Human papillomavirus (HPV); P53; Proliferation

Indexed keywords

PROTEIN P53;

ARTICLE; CELL PROLIFERATION; CHROMOSOME 3Q; CHROMOSOME ABERRATION; COMPARATIVE STUDY; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC STABILITY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PLOIDY; PRIORITY JOURNAL; UTERINE TUBE CARCINOMA; VIRUS GENOME;

EID: 0031863236     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199807000-00009     Document Type: Article

References (50)

1. Hanton EM, Malkasian GD, Dahlin DC, Pratt J. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1966;94:832-9.
2. Dodson MG, Ford JH, Averette HE. Clinical aspects of fallopian tube carcinoma. Obstet Gynecol 1970;36:935-9.
3. Engeler V, Reinisch E, Schreiner WE. Das primäre tubenkarzinom - eine klinische studie an 37 patienten. Geburtsh Frauenheilkd 1981;41:325-9.
4. Pfleiderer A. Tumoren der Tube. In: Bender HG (ed). Gynäkologische Onkologie. Stuttgart, Germany/New York, NY: Thieme, 1984:220-5.
5. Pfeiffer P, Mogensen H, Amtrup F, Honore E. Primary carcinoma of the fallopian tube. Acta Oncol 1989;28:7-11.
6. Deppe G, Malone Jr M, Lawrence W. Cancer of the fallopian tube. In: Gusberg S, Shingleton H, Deppe G (eds). Female genital cancer. New York, NY: Churchill Livingstone 1988:427-34.
7. Hellström AC, Hue J, Silfverswärd C, Auer G. DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer. Int J Gynecol Cancer 1994;4:408-13.
8. Rosen AC, Graf AH, Hacker GW, Klein M, Lahousen M, Vavra N, Reiner A. Prognostic impact of DNA content and AUER classification in primary fallopian tube carcinoma. Cancer Lett 1995; 92:97-103.
9. Lacy MQ, Hartmann LC, Keeney GL, et al. c-erbB-2 and p53 expression in fallopian tube carcinoma. Cancer 1995;75:2891-6.
10. Zheng W, Sung J, Cao P, et al. Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube. Gynecol Oncol 1997;64:38-48.
11. Curcio S. Studio citogenetico di un carcinoma primitivo della salpinge. Arch Ostet Ginecol 1966;71:450-6.
12. Weise W, Büttner HH. Chromosome analysis of a primary carcinoma of the Fallopian tube. Humangenetik 1972;15:196-7.
13. Tharapel SA, Qumsiyeh MB, Photopulos G. Numerical chromosome abnormalities associated with early clinical stages of gynecological tumors. Cancer Genet Cytogenet 1991;55:89-96.
14. Bardi G, Sukhikh T, Pandis N, Hølund B, Heim S. Complex karyotypic abnormalities in a primary carcinoma of the fallopian tube. Genes Chromosomes Cancer 1994;10:207-9.
15. Kallioniemi A, Kallioniemi O-P, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
16. Speicher MR, du Manoir S, Schröck E, et al. Molecular cytogenetic analysis of formalin-fixed, paraffin embedded solid tumors by comparative hybridization after universal DNA-amplification. Hum Mol Genet 1993;2:1907-14.
17. Isola J, DeVries S, Chu L, Ghazrini S, Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994;145:1301-8.
18. Pettersson F. Staging rules for gestational trophoblastic tumors and fallopian tube cancer. Acta Obstet Gynecol Scand 1992;71:224-5.
19. Hu CY, Taymor ML, Hertig AT. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1959;59:58-67.
20. Sedlis A. Primary carcinoma of the fallopian tube. Obstet Gynecol Surv 1961;166:209-26.
21. Auer GU, Heselmeyer KM, Steinbeck RG, Munck-Wikland E, Zetterberg A. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinomas. Virchows Arch 1994;424:343-7.
22. Auer G, Caspersson T, Wallgren A. DNA content and survival in mammary carcinoma. Anal Quant Cytol Histol 1980;2:161-5.
23. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996;15:234-45.
24. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
25. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
26. Heselmeyer K, Schröck E, du Manoir S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996;93:479-84.
27. Ried T, Just K, Holtgreve-Grez H, et al. Comparative genomic hybridization of formalin fixed, paraffin embedded breast carcinomas reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 1995;55:5415-23.
28. Ried T, Petersen I, Holtgreve-Grez H, et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 1994;54:1801-6.
29. Schröck E, Thiel G, Lozanova T, et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 1994;144:1203-18.
30. Heselmeyer K, Macville M, Schröck E, et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 1997; 19:233-40.
31. Heselmeyer K, du Manoir S, Blegen H, et al. A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas. Br J Cancer 1997;76: 1271-8.
32. Levin NA, Brzoska P, Gupta N, Minna JD, Gray JW, Christman MF. Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res 1994;54:5086-91.
33. Levin NA, Brzoska P, Warnock ML, Gray JW, Christman MF. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer 1995;13:175-85.
34. Iwabuchi H, Sakamoto M, Sakunaga H, et al. Genetic analysis of benign, low-grade and high-grade ovarian tumors. Cancer Res 1995;55:6172-80.
35. Brzoska PM, Levin NA, Fu KK, et al. Frequent novel DNA copy number increases in squamous cell head and neck tumors. Cancer Res 1995;55:3055-9.
36. Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 1995;55:1010-3.
37. Arnold N, Hagele L, Walz L, et al. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 1996;16:46-54.
38. Petersen I, Bujard M, Petersen S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997;57:2331-5.
39. Soder A, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997;14:1013-21.
40. Sakamoto M, Sakunaga H, Yang-Feng T, et al. Analysis of genetic aberrations in ovarian cancers using comparative genomic hybridization. Proceedings of the American Association for Cancer Research 1993;34:210.
41. Baker VV, Borst MP, Dixon D, Hatch KD, Shingleton HM, Miller D. C-myc amplification in ovarian cancer. Gynecol Oncol 1990; 38:340-2.
42. Pejovic T, Heim S, Mandahl N, et al. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 1992;4:58-68.
43. Mark HF, Hann E, Mikumo R, Lauchlan S, Beauregard L, Braun L. Cytogenetic characterization of three cell lines derived from primary cervical tumors. Ann Clin Lab Sci 1995;25:185-99.
44. Mizuuchi H, Mori Y, Sato K, et al. High incidence of point mutation in K-ras codon 12 in carcinoma of the Fallopian tube. Cancer 1995;76:86-90.
45. Filmus J, Trent JM, Pullano R, Buick RN. A cell line from an ovarian carcinoma with amplification of the K-ras gene. Cancer Res 1986;46:5179-82.
46. Chenevix-Trench G, Leary J, Kerr J, et al. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 1992;7:1059-65.
47. Runnebaum IB, Köhler T, Stickeler E, Rosenthal HE, Kieback DG, Kreienberg R. p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma. Br J Cancer 1996;74:1157-60.
48. Navani SS, Alvarado-Cabrero I, Young RH, Scully RE. Endometrioid carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases. Gynecol Oncol 1996;63:371-8.
49. Hellström AC, Silfverswärd C, Nilsson B, Pettersson F. Carcinoma of the fallopian tube. A clinical and histopathologic review. The Radiumhemmet series. Int J Gynecol Cancer 1994;4:395-400.
50. Isola JJ, Kallioniemi O-P, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995;147:905-11.